baber/WOPTO huggingface dataset:
Patent AU-755571-B2 (AU)
Title: Stabilized high vacuum drying installation for industrial hides and similar products
Inventor: POLATO ANTONIO
IPC: C14B1/58
Filed: 1999-06-28
Granted: 2002-12-19
Abstract: A stabilised high vacuum drying installation for industrial hides and similar products includes a plurality of drying beds (2, 2', 2'') with heating platforms (3, 3', 3'') and hermetic covers (4, 4', 4''), vacuum means (7) connected to the drying beds to extract vapours coming from the hides and to reduce the pressure to minimum working values (Pi), a circuit with valve means (10, 10', 10''; 11, 11', 11'') to selectively connect the drying beds to the vacuum means. The valve means include, downstream of every drying bed, at least one cutoff valve (10, 10', 10'') for selectively connecting such bed, initially at atmospheric pressure, to the vacuum means (7), and at least one check valve (11, 11', 11'') for isolating automatically the remaining beds already at working pressure so as to avoid pressure oscillations in their interior. The vacuum means (7) include a primary vacuum pump (8) suitable to reduce the pressure in the circuit to a predetermined value (Ps) superior to the working minimum value (Pi) and a secondary vacuum pump (9) suitable to co-operate with the primary vacuum pump (8) to reduce the pressure in the circuit to the minimum working value (Pi).
Patent AU-578296-B2 (AU)
Title: Admixer for two flowing liquids
Inventor: HEPPERLE WILLI
IPC: F16K11/14
Filed: 1985-07-15
Granted: 1988-10-20
Abstract: An admixer for delivering soluble additives to flowing liquids containing a valve with a rotary valve body and a container for receiving the additive in tablet form located in the extension of the valve body. The valve body contains an outer channel guide which can be made to coincide with the valve inlet port and a tubular water guide leading through the interior of the valve body.
Patent AU-670447-B2 (AU)
Title: Method and circuit for charging batteries
Inventor: ETTEL VICTOR ALEXANDER
IPC: H02J7/00
Filed: 1993-07-14
Granted: 1996-07-18
Abstract: A battery charge is provided which automatically controls the charging process independent of individual battery construction or temperature. Control of the charging process is achieved by periodically interrupting the charging current, determining resistance-free voltage of the battery in fixed intervals after interruptions of current, and comparing the resistance-free voltage with a reference voltage. Reference voltage is automatically determined for each recharging subject by analyzing the change in resistance-free voltage with respect to time during an initial, constant current period to locate certain characteristic points indicative of the onset of overcharge. The charging current is reduced as necessary, so that the resistance-free voltage does not exceed the reference voltage and significant overcharge is avoided.
Patent AU-706435-B2 (AU)
Title: Fiber-optics illuminated fuel dispenser
Inventor: TRYON JOHN FREDERICK
IPC: G09F9/30
Filed: 1995-12-04
Granted: 1999-06-17
Abstract: A panel assembly including a translucent panel and a fiber-optic strip disposed on the back of the translucent panel for imparting illumination to at least part of the translucent panel where the illumination of the fiber-optic strip by a light source results in illumination of the fiber-optic strip and at least part of the translucent panel.
Patent AU-712868-B2 (AU)
Title: Elastin, and elastin based bio-materials and process
Inventor: GREGORY KENTON W
IPC: B32B5/02
Filed: 1995-04-04
Granted: 1999-11-18
Abstract: The present invention relates to an elastin-based biomaterial and to a method of using same to effect tissue repair or replacement. The invention further relates to a method of securing the biomaterial to existing tissue.
Patent AU-617563-B2 (AU)
Title: Process to produce a surface coating from molybdenum by thermal spraying
Inventor: KREYE HEINRICH
IPC: C23C4/08
Filed: 1989-12-13
Granted: 1991-11-28
Abstract: The invention relates to a method for applying a molybdenum coating by thermal spraying. In known methods, substantial restrictions in carrying out the method and hence also quality defects in the layer produced must be accepted because of the high melting point of molybdenum. In the method according to the invention, in which the coating is produced by flame spraying or high-speed flame spraying with a pre-oxidised or partially oxidised molybdenum spraying material, the said disadvantages are overcome and higher qualities are achieved.
Patent AU-767425-B2 (AU)
Title: An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport
Inventor: ABRAHAMSSON BERTIL
IPC: A61K31/554
Filed: 2000-04-19
Granted: 2003-11-13
Abstract: An oral pharmaceutical formulation comprising an inhibitor compound of the ileal bile acid transport (IBAT inhibitor compound) and a therapeutically acceptable carrier characterised in that the formulation is designed to deliver the IBAT inhibitor compound in the ileum. The IBAT inhibitor compound can also be administered in combination with a bile acid binder to alleviate possible side effects of therapy with IBAT inhibitor compound, such as for instance diarrhoea. The bile acid binder may be formulated for colon release.
Patent AU-666576-B2 (AU)
Title: NANBV diagnostics and vaccines
Inventor: HOUGHTON MICHAEL
IPC: C12Q1/68
Filed: 1993-09-21
Granted: 1996-02-15
Abstract: A pharmaceutical composition comprising a hepatitis C virus (HCV) antisense polynucleotide which is selectively hybridizable for the sense strand of the genome of an HCV, wherein the polynucleotide comprises a contiguous sequence of at least 8 nucleotides complementary to the sense strand of the genome of an HCV and a pharmaceutically acceptable excipient, wherein HCV is characterized by:  (i) a positive stranded RNA genome; (ii) said genome comprising an open reading frame (ORF) encoding a polyprotein; and (iii) said polyprotein is encoded by an HCV genome wherein the HCV genome has an homology at the polypeptide level of at least 40% to the 169 amino acid sequence shown in Figure 11.
Patent AU-644064-B2 (AU)
Title: Hydroxamic acid based collagenase inhibitors
Inventor: CAMPION COLIN
IPC: A61K31/381
Filed: 1989-11-23
Granted: 1993-12-02
Abstract: Compounds of general formula I:    <IMAGE>  (I)  wherein: R1 represents a C1-C6 alkyl, phenyl, thiophenyl, substituted phenyl, phenyl(C1-C6)alkyl, heterocyclyl, (C1-C6)alkylcarbonyl phenacyl or substituted phenacyl group; or, when n=O, R1 represents SRx, wherein Rx represents a group:   <IMAGE>   R2 represents a hydrogen atom or a C1-C6 alkyl, C1-C6 alkenyl, phenyl(C1-C6)alkyl, cycloalkyl(C1-C6)alkyl or cycloalkenyl(C1-C6)alkyl group; R3 represents an amino acid residue with R or S stereochemistry or a C1-C6 alkyl, benzyl, (C1-C6 alkoxy)benzyl or benzyloxy(C1-C6 alkyl) group; R4 represents a hydrogen atom or a C1-C6 alkyl group; R5 represents a hydrogen atom or a methyl group; n is an integer having the value 0, 1 or 2; and A represents a C1-C6 hydrocarbon chain, optionaly substituted with one or more C1-C6 alkyl, phenyl or substituted phenyl groups; and their salts and N-oxides are collagenase inhibitors are and useful in the management of disease involving tissue degradation and/or the promotion of wound healing. Diseases involving tissue degradation include arthropathy (particularly rheumatoid arthritis), inflammation, dermatological diseases, bone resorption diseases and tumor invasion.
Patent AU-670128-B2 (AU)
Title: Aquaculture system and methods for using the same
Inventor: FAHS RICHARD W II
IPC: A01K63/00
Filed: 1993-09-20
Granted: 1996-07-04
Abstract: The present invention is directed to apparatus and a method for maintaining and growing a primary cultured species and secondary organisms essential to the growth of the primary species in an aquaculture system in which the parameters which affect the maintenance and growth of the primary cultured species are carefully monitored and adjusted on a substantially continuous basis. The apparatus comprises a tank for holding an aqueous medium and the primary species, nutrient supply equipment, equipment for selectively removing the aqueous medium from the tank, apparatus for removing particulate matter from the aqueous medium removed from the tank, a sterilizer for sterilizing the aqueous medium removed from the tank, equipment for removing toxins from the aqueous medium removed from the tank without biological filtration, and a station with associated equipment for bringing the aqueous medium to a steady state suitable for the growth and survival of the primary species. Conduits, pumps and associated valving are provided for transferring the aqueous medium among the various treatment stations and for returning the aqueous medium to the tank after it has been treated by any or all of the foregoing treatment equipment.
Patent AU-708454-B2 (AU)
Title: Photochemically cross-linked polysaccharide derivatives as supports for the chromatographic separation of enantiomers
Inventor: FRANCOTTE ERIC
IPC: B01J20/24
Filed: 1996-02-24
Granted: 1999-08-05
Abstract: PCT No. PCT/EP96/00773 Sec. 371 Date Sep. 2, 1997 Sec. 102(e) Date Sep. 2, 1997 PCT Filed Feb. 24, 1996 PCT Pub. No. WO96/27615 PCT Pub. Date Sep. 12, 1996The present invention relates to photochemically cross-linked derivatives of general formulae (IA) and (IB), wherein R is a polysaccharide radical in which the OH groups have been esterified as OR' groups or converted into a carbamate (urethane), R1, and R2 are each independently lower alkyl or unsubstituted or substituted aryl, X is a direct bond or phenylene, m is 0 or 1, and n is 0 or an integer from 1 to 20, to processes from the preparation thereof and to the use thereof. The compounds of general formula (IA) and (IB) can be used as supports in the chromatographic separation of enantiomers.
Patent AU-679940-B2 (AU)
Title: Bifidobacterium growth promoter
Inventor: TOSHIHIKO ASANO
IPC: A23L29/00
Filed: 1993-10-14
Granted: 1997-07-17
Abstract: A bifidobacterium growth promoter containing gluconic acid, a nontoxic salt thereof and/or glucono- delta -lactone as the active ingredient. It has not only a selective bifidobacterium growth promoter effect but also the effect of inhibiting the growth of deleterious bacteria. Further, it is reduced in the rate of digestion and absorption in the upper alimentary tract and hence has excellent characteristics as a bifidus factor. Therefore, this promoter can be used per se or as an additive for various food and drink to provide functional food and drink, thus being remarkably useful from the viewpoint of health improvement.
Patent AU-575707-B2 (AU)
Title: Controlling conditions in electrolysis of sulfate containing brine
Inventor: BISSOT THOMAS CHARLES
IPC: C25B1/46
Filed: 1986-01-23
Granted: 1988-08-04
Abstract: In an improved process for the electrolysis of sulfate-containing brine in a membrane cell, the thickness of the membrane, the concentration of sodium sulfate in the brine and the current density through the membrane in the operating cell are controlled to prevent damage to the membranes.
Patent AU-678564-B2 (AU)
Title: Improved storage of parenterally administerable products
Inventor: BOURBOULOU YVES
IPC: B65D81/20
Filed: 1993-11-02
Granted: 1997-06-05
Abstract: PCT No. PCT/SE93/00915 Sec. 371 Date Jun. 30, 1995 Sec. 102(e) Date Jun. 30, 1995 PCT Filed Nov. 2, 1993 PCT Pub. No. WO94/10064 PCT Pub. Date May 11, 1994The present invention is directed to the method and use of a helium containing gas for improving the physical stability of packaged sensitive products, especially those products which contain a fat emulsion.
Patent AU-584422-B2 (AU)
Title: Method and apparatus for automated synthesis of peptides
Inventor: HORN MARCUS J
IPC: B01J19/00
Filed: 1986-04-17
Granted: 1989-05-25
Abstract: A method for monitoring a solid-phase peptide synthesis for free amino ends of unreacted peptide chains, the monitoring occurring at the end of each addition of a blocked amino acid to the peptide chains which are anchored to the solid phase. The method includes reacting the solid phase with a monitoring agent that forms a covalent bond with unblocked amino groups. The solid phase is then washed to remove the unreacted monitoring agent. A cleaving reagent is then used to selectively remove the covalently bound monitoring reagent from the ends of the unblocked peptide chains, while leaving the blocked chains intact. The amount of monitoring agent thus removed is then quantitatively measured to determine what proportion of the initial peptide chains failed to react with the blocked amino acid. Preferred monitoring agents for use in this process include trityl (triphenylmethyl) -based groups, and particularly preferred agents are trityl, monomethoxytrityl, dimethoxytrityl, and trimethoxytrityl chlorides.
Patent AU-730485-B2 (AU)
Title: Canopy structure for sun shade
Inventor: WILLIAMS MARVIN E
IPC: E06B9/262
Filed: 1998-01-09
Granted: 2001-03-08
Abstract: A shade canopy structure has several substantially parallel, but laterally spaced rafter members, each rafter member having longitudinally extending tracks on its laterally opposite sides. The rafters define a plurality of laterally spaced openings. A plurality of cross beams extend laterally between adjacent rafter members and have their ends engaged in the track for sliding along the track. This forms a plurality of laterally spaced tiers of cross beams for each of the laterally spaced openings. A plurality of flexible, laterally spaced opaque sheets, each are extendible along one of the laterally spaced openings and each is attached to a tier of cross beams at spaced locations along the sheet so that each sheet may be independently drawn to an extended position and releasably latched in an extended position, or manually withdrawn to a retracted position.
Patent AU-770296-B2 (AU)
Title: Delivery system for biological material
Inventor: HILGERS ARNOLD
IPC: A61K31/711
Filed: 2000-07-07
Granted: 2004-02-19
Abstract: The present invention relates to a composition and method for delivery of biological material, especially nucleic acids into target cells and into the nucleus.  <IMAGE>
Patent AU-676723-B2 (AU)
Title: Cosmetic or topical use of an aqueous dispersion based on non-volatile organopolysiloxanes and an acrylamide or homolymeric copolymer type cross-linked methacryloyloxyethyltrimethylammonium chloride polymer
Inventor: CAUWET DANIELE
IPC: A61K8/04
Filed: 1994-03-15
Granted: 1997-03-20
Abstract: PCT No. PCT/FR94/00275 Sec. 371 Date Sep. 13, 1995 Sec. 102(e) Date Sep. 13, 1995 PCT Filed Mar. 15, 1994 PCT Pub. No. WO94/21224 PCT Pub. Date Sep. 29, 1994The cosmetic or topical use of an aqueous dispersion at least of a cosmetically acceptable aqueous medium containing an acrylamide homopolymeric or copolymer cross-linked methacryloyloxyethyl trimethylammonium chloride polymer, and a non-volatile organopolysiloxane selected from polyalkylsiloxanes, polyarylsiloxanes, polyalkylarylsiloxanes, silicone resins and gums, and organomodified polysiloxanes, with the exception of polysiloxanes comprising polyethyleneoxy and/or polypropyleneoxy, carboxylate or bisulfite groupings, is disclosed.
Patent AU-638747-B2 (AU)
Title: Improvements in or relating to organic compounds
IPC: C07C323/25
Filed: 1990-10-01
Granted: 1993-07-08
Abstract: Compounds of formula I <CHEM> wherein R1 and R2 are the same or different and each represent hydrogen, alkyl, alkenyl, cycloalkyl, aryl or aralkyl are produced by a new environmentally acceptable process.
Patent AU-688333-B2 (AU)
Title: Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic T lymphocytes against HIV
Inventor: BERZOFSKY JAY A
IPC: C07K19/00
Filed: 1994-05-13
Granted: 1998-03-12
Abstract: Peptide constructs comprised of multideterminant T helper peptides from the envelope glycoprotein of HIV previously identified to induce proliferative responses in four different haplotypes of mice and IL-2 responses in 52-73% of HIV positive, flu positive patients (cluster peptides), were co-linearly synthesized with the peptide 18 of the V3 loop of HIV-1 gp 160, corresponding to the principal neutralizing determinant of HIV-IIIB and also shown to contain a dominant CTL epitope. Cognate help for peptide 18 antibody was elicited following a single immunization in all strains of mice which had previously responded to a T cell epitope encompassed by the peptides. In two strains of mice, the level of neutralizing antibody achieved was comparable to levels adequate for protection from homologous viral challenge in chimpanzees. After a single boost, much higher antibody titers for 90% neutralization in the range of 1:1000 to 1:16,000 were achieved. Spleen cells from mice of three distinct MHC haplotypes sharing the D<SUP>d </SUP>class I MHC molecule but with different class II molecules, immunized with the compound peptides, exhibited enhanced gp160-specific CTL activity.
Patent AU-661454-B2 (AU)
Title: Ironing apparatus
Inventor: BERNSTEIN DAVID SYLVANE
IPC: D06F81/08
Filed: 1990-11-07
Granted: 1995-07-27
Abstract: An ironing table (40) has an ironing board (41) which is perforated by a number of bores. A vacuum pump or suction fan is mounted in a housing (47) adjacent the board (41) and can communicate with a chamber (46) disposed below the board (41). The pump or fan operate to lower the pressure in the chamber (46) thereby forming a pressure gradient between top and bottom surfaces of the ironing board (41) whereby steam will be positively drawn from an iron through the garment being ironed, into the bores and into the chamber (46). The steam will condense on the relatively cooler walls of the chamber (46) and will drain to one end due to the inclined base of the chamber (46) and can be drained away after ironing via drainage tap.
Patent AU-638555-B2 (AU)
Title: Method for preparing process flavourings
Inventor: POTMAN RONALD PETER
IPC: A23L27/22
Filed: 1991-03-06
Granted: 1993-07-01
Abstract: The present invention is concerned with method for preparing process flavourings, comprising the steps of:   (a) mildly oxidizing fat to such a degree that the anisidine value of the fat is increased by at least a factor 1.5,   (b) preparing a Maillard reaction mixture comprising:   (1) a carbohydrate ingredient selected from the group consisting of reducing carbohydrate, precursors of such carbohydrates, heat-degradation products of such carbohydrates and mixtures thereof,   (2) a nitrogen compound with general formula NHRR', where R and R' represent hydrogen, aliphatic group or aromatic group and where R and R' may be the same or different, and (3) the oxidized fat obtained in step (a), the weight ratio of carbohydrate to nitrogen compound exceeding 1:20, and   (c) maintaining the reaction mixture at a temperature of more than 50 DEG C for at least 2 minutes. It was found the incorporation of mildly oxidized fat in a Maillard reaction mixture upon subsequent heat treatment generates a relatively strong and in addition to that a balanced process flavouring due to the fact that also non-typical Maillard-type process flavourings are formed. n
Patent AU-542514-B2 (AU)
Title: A method of eliminating discomforting flickering when viewingx-ray film in a light cabinet, and a flicker-eliminating unit for use in a light cabinet
Inventor: GAJECKI RICKARD
IPC: H05B41/24
Filed: 1981-06-26
Granted: 1985-02-21
Abstract: PCT No. PCT/SE81/00190 Sec. 371 Date Mar. 10, 1982 Sec. 102(e) Date Mar. 10, 1982 PCT Filed Jun. 26, 1981 PCT Pub. No. WO82/00367 PCT Pub. Date Feb. 4, 1982.A method of eliminating discomforting flickering when viewing X-ray films in a light cabinet using fluorescent lamps, and a flicker-eliminating circuit for use in the light cabinet.
Patent AU-738578-B2 (AU)
Title: Improved fluorescence sensing device
Inventor: COLVIN ARTHUR E JR
IPC: G01N21/77
Filed: 1998-05-12
Granted: 2001-09-20
Abstract: A fluorescence sensing device for determining the presence or concentration of an analyte in a liquid or gaseous medium is constructed of a fiber optic plate comprising optical fibers having relatively small numerical apertures. The fiber optic plate is positioned on a photodetector and has a layer of analyte permeable fluorescent matrix or coated waveguide material on its top surface. The fluorescent matrix or waveguide coating contains indicator molecules whose fluorescence is affected by the local presence of analyte. A light source emits light into the fluorescent matrix in a direction generally parallel to the top surface of the fiber optic plate. Upon absorbing light from the light source, indicator molecules in the fluorescent matrix emit fluorescent light which is transmitted through the fiber optic plate to the photodetector.
Patent AU-576701-B2 (AU)
Title: Span variation in two blade razor
Inventor: FERRARO FRANK A
IPC: B26B21/54
Filed: 1987-08-28
Granted: 1988-09-01
Abstract: A blade assembly (10) comprises first and second blades (24) and (24') which are pivotally mounted to the rest of the assembly (10). This enables the span of each blade to be altered in response to the amount of shaving force generated by the user.
Patent AU-632941-B2 (AU)
Title: The expression of phytase in plants
IPC: C12N15/00
Filed: 1991-03-25
Granted: 1993-01-14
Abstract: The present invention provides for the expression of phytase in transgenic plants or plant organs and methods for the production of such plants. DNA expression constructs are provided for the transformation of plants with a gene encoding phytase under the control of regulatory sequences which are capable of directing the expression of phytase. These regulatory sequences include sequences capable of directing transcription in plants, either constitutively, or stage and/or tissue specific, depending on the use of the plant or parts thereof. The transgenic plants and plant organs provided by the present invention may be applied to a variety of industrial processes either directly, e.g. in animal feeds or alternatively, the expressed phytase may be extracted and if desired, purified before application.
Patent AU-782337-B2 (AU)
Title: Vaccines against Neisseria infection
Inventor: PLESTED JOYCE SUSAN
IPC: A61K39/095
Filed: 2000-10-02
Granted: 2005-07-21
Abstract: The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine comprising one or more immunogenic components for Neisseria serogroups, as well as antibodies to the immunogenic components and methods of preventing and treating Neisseria infections. The immunogens are based on elements of the inner core lipopolysaccharide.
Patent AU-545133-B2 (AU)
Title: Acetylene storage vessel
Inventor: FLANIGEN EDITH MARIE
IPC: C04B28/20
Filed: 1982-01-18
Granted: 1985-07-04
Abstract: An acetylene storage vessel having an asbestos free, hardened, porous calcium silicate filler material comprising at least 35 percent by weight crystalline phase reinforced by alkali resistant glass fiber and a method for the manufacture thereof.
Patent AU-602732-B2 (AU)
Title: Absorbable bone plate
Inventor: TUNC DEGER
IPC: A61B17/80
Filed: 1987-10-26
Granted: 1990-10-25
Abstract: An absorbable bone plate resistant to breakage fabricated with such interrelated dimensions that the stresses developed along the length of the plate when the plate is implanted are relatively constant and do not vary by more than 20% and preferably do not vary by more than 10%.
Patent AU-594907-B2 (AU)
Title: N-substituted thio alkyl phenothiazines
Inventor: SALOMON MARY FRISINGER
IPC: C07D279/22
Filed: 1987-09-09
Granted: 1990-03-15
Abstract: This invention describes phenothiazine derivatives which are N-substituted and which contain an additional sulfur molecule in the N substituent.
Patent AU-592028-B2 (AU)
Title: A digital register cell
Inventor: RABAEY DIRK HERMAN LUTGARDIS C
IPC: H03M7/50
Filed: 1987-12-16
Granted: 1989-12-21
Abstract: The present Pulse Code Modulation (PCM) translators include a first translator (COLI) for translating a PCM input word coded according to the A or mu-law into a linear PCM output word and a second translator (LICO) for translating a linear PCM input word into a PCM output word coded according to the A or mu-law. The choice of the A-law or mu-law is done by selecting the binary value of a single control bit (A).